 | • レポートコード：GIR-2104Z09647 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、mTOR阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。mTOR阻害剤の種類別市場規模（ラパミューン、トリセル、アフィニトール、ゾルトレス）、用途別市場規模（腫瘍治療、腎臓移植、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・mTOR阻害剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：LC Laboratories、Teva Pharmaceutical Industries Ltd.、Exelixis、Novartis Oncology、Pfizer、GSK ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ラパミューン、トリセル、アフィニトール、ゾルトレス ・用途別分析2016年-2026年：腫瘍治療、腎臓移植、その他 ・mTOR阻害剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・mTOR阻害剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・mTOR阻害剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・mTOR阻害剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・mTOR阻害剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The mTOR Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global mTOR Inhibitors size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global mTOR Inhibitors market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
mTOR Inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rapamune
Torisel
Afinitor
Zortress
Market segment by Application can be divided into
Tumor Treatment
Kidney Transplant
Others
The key market players for global mTOR Inhibitors market are listed below:
LC Laboratories
Teva Pharmaceutical Industries Ltd.
Exelixis
Novartis Oncology
Pfizer
GSK
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 mTOR Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global mTOR Inhibitors Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Rapamune
1.2.3 Torisel
1.2.4 Afinitor
1.2.5 Zortress
1.3 Market Analysis by Application
1.3.1 Overview: Global mTOR Inhibitors Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Tumor Treatment
1.3.3 Kidney Transplant
1.3.4 Others
1.4 Global mTOR Inhibitors Market Size & Forecast
1.4.1 Global mTOR Inhibitors Sales in Value (2016-2026))
1.4.2 Global mTOR Inhibitors Sales in Volume (2016-2026)
1.4.3 Global mTOR Inhibitors Price by Type (2016-2026) & (USD/Unit)
1.5 Global mTOR Inhibitors Production Capacity Analysis
1.5.1 Global mTOR Inhibitors Total Production Capacity (2016-2026)
1.5.2 Global mTOR Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 mTOR Inhibitors Market Drivers
1.6.2 mTOR Inhibitors Market Restraints
1.6.3 mTOR Inhibitors Trends Analysis
2 Manufacturers Profiles
2.1 LC Laboratories
2.1.1 LC Laboratories Details
2.1.2 LC Laboratories Major Business
2.1.3 LC Laboratories mTOR Inhibitors Product and Services
2.1.4 LC Laboratories mTOR Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Teva Pharmaceutical Industries Ltd.
2.2.1 Teva Pharmaceutical Industries Ltd. Details
2.2.2 Teva Pharmaceutical Industries Ltd. Major Business
2.2.3 Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Product and Services
2.2.4 Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Exelixis
2.3.1 Exelixis Details
2.3.2 Exelixis Major Business
2.3.3 Exelixis mTOR Inhibitors Product and Services
2.3.4 Exelixis mTOR Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis Oncology
2.4.1 Novartis Oncology Details
2.4.2 Novartis Oncology Major Business
2.4.3 Novartis Oncology mTOR Inhibitors Product and Services
2.4.4 Novartis Oncology mTOR Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer mTOR Inhibitors Product and Services
2.5.4 Pfizer mTOR Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK mTOR Inhibitors Product and Services
2.6.4 GSK mTOR Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 mTOR Inhibitors Sales by Manufacturer
3.1 Global mTOR Inhibitors Sales in Volume by Manufacturer (2019-2021e)
3.2 Global mTOR Inhibitors Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in mTOR Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 mTOR Inhibitors Manufacturer Market Share
3.4.2 Top 6 mTOR Inhibitors Manufacturer Market Share
3.5 Global mTOR Inhibitors Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and mTOR Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global mTOR Inhibitors Market Size by Region
4.1.1 Global mTOR Inhibitors Sales in Volume by Region (2016-2026)
4.1.2 Global mTOR Inhibitors Revenue by Region (2016-2026)
4.2 North America mTOR Inhibitors Revenue (2016-2026)
4.3 Europe mTOR Inhibitors Revenue (2016-2026)
4.4 Asia-Pacific mTOR Inhibitors Revenue (2016-2026)
4.5 South America mTOR Inhibitors Revenue (2016-2026)
4.6 Middle East and Africa mTOR Inhibitors Revenue (2016-2026)
5 Market Segment by Type
5.1 Global mTOR Inhibitors Sales in Volume by Type (2016-2026)
5.2 Global mTOR Inhibitors Revenue by Type (2016-2026)
5.3 Global mTOR Inhibitors Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global mTOR Inhibitors Sales in Volume by Application (2016-2026)
6.2 Global mTOR Inhibitors Revenue by Application (2016-2026)
6.3 Global mTOR Inhibitors Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America mTOR Inhibitors Sales by Type (2016-2026)
7.2 North America mTOR Inhibitors Sales by Application (2016-2026)
7.3 North America mTOR Inhibitors Market Size by Country
7.3.1 North America mTOR Inhibitors Sales in Volume by Country (2016-2026)
7.3.2 North America mTOR Inhibitors Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe mTOR Inhibitors Sales by Type (2016-2026)
8.2 Europe mTOR Inhibitors Sales by Application (2016-2026)
8.3 Europe mTOR Inhibitors Market Size by Country
8.3.1 Europe mTOR Inhibitors Sales in Volume by Country (2016-2026)
8.3.2 Europe mTOR Inhibitors Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific mTOR Inhibitors Sales by Type (2016-2026)
9.2 Asia-Pacific mTOR Inhibitors Sales by Application (2016-2026)
9.3 Asia-Pacific mTOR Inhibitors Market Size by Region
9.3.1 Asia-Pacific mTOR Inhibitors Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific mTOR Inhibitors Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America mTOR Inhibitors Sales by Type (2016-2026)
10.2 South America mTOR Inhibitors Sales by Application (2016-2026)
10.3 South America mTOR Inhibitors Market Size by Country
10.3.1 South America mTOR Inhibitors Sales in Volume by Country (2016-2026)
10.3.2 South America mTOR Inhibitors Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa mTOR Inhibitors Sales by Type (2016-2026)
11.2 Middle East & Africa mTOR Inhibitors Sales by Application (2016-2026)
11.3 Middle East & Africa mTOR Inhibitors Market Size by Country
11.3.1 Middle East & Africa mTOR Inhibitors Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa mTOR Inhibitors Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 mTOR Inhibitors Typical Distributors
12.3 mTOR Inhibitors Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global mTOR Inhibitors Revenue by Type, (USD Million), 2021-2026
Table 2. Global mTOR Inhibitors Revenue by Application, (USD Million), 2021-2026
Table 3. LC Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. LC Laboratories Major Business
Table 5. LC Laboratories mTOR Inhibitors Product and Services
Table 6. LC Laboratories mTOR Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Teva Pharmaceutical Industries Ltd. Major Business
Table 9. Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Product and Services
Table 10. Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Exelixis Basic Information, Manufacturing Base and Competitors
Table 12. Exelixis Major Business
Table 13. Exelixis mTOR Inhibitors Product and Services
Table 14. Exelixis mTOR Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis Oncology Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Oncology Major Business
Table 17. Novartis Oncology mTOR Inhibitors Product and Services
Table 18. Novartis Oncology mTOR Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer mTOR Inhibitors Product and Services
Table 22. Pfizer mTOR Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. GSK Basic Information, Manufacturing Base and Competitors
Table 24. GSK Major Business
Table 25. GSK mTOR Inhibitors Product and Services
Table 26. GSK mTOR Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global mTOR Inhibitors Sales by Manufacturer (2019-2021e) & (K Units)
Table 28. Global mTOR Inhibitors Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in mTOR Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global mTOR Inhibitors Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and mTOR Inhibitors Production Site of Key Manufacturer
Table 32. Global mTOR Inhibitors Sales by Region (2016-2021e) & (K Units)
Table 33. Global mTOR Inhibitors Sales by Region (2021-2026) & (K Units)
Table 34. Global mTOR Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global mTOR Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 36. Global mTOR Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 37. Global mTOR Inhibitors Sales by Type (2021-2026) & (K Units)
Table 38. Global mTOR Inhibitors Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global mTOR Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 40. Global mTOR Inhibitors Price by Type (2016-2021e) & (USD/Unit)
Table 41. Global mTOR Inhibitors Price by Type (2021-2026) & (USD/Unit)
Table 42. Global mTOR Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 43. Global mTOR Inhibitors Sales by Application (2021-2026) & (K Units)
Table 44. Global mTOR Inhibitors Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global mTOR Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 46. Global mTOR Inhibitors Price by Application (2016-2021e) & (USD/Unit)
Table 47. Global mTOR Inhibitors Price by Application (2021-2026) & (USD/Unit)
Table 48. North America mTOR Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 49. North America mTOR Inhibitors Sales by Country (2021-2026) & (K Units)
Table 50. North America mTOR Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America mTOR Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 52. North America mTOR Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 53. North America mTOR Inhibitors Sales by Type (2021-2026) & (K Units)
Table 54. North America mTOR Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 55. North America mTOR Inhibitors Sales by Application (2021-2026) & (K Units)
Table 56. Europe mTOR Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 57. Europe mTOR Inhibitors Sales by Country (2021-2026) & (K Units)
Table 58. Europe mTOR Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe mTOR Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe mTOR Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 61. Europe mTOR Inhibitors Sales by Type (2021-2026) & (K Units)
Table 62. Europe mTOR Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 63. Europe mTOR Inhibitors Sales by Application (2021-2026) & (K Units)
Table 64. Asia-Pacific mTOR Inhibitors Sales by Region (2016-2021e) & (K Units)
Table 65. Asia-Pacific mTOR Inhibitors Sales by Region (2021-2026) & (K Units)
Table 66. Asia-Pacific mTOR Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific mTOR Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific mTOR Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 69. Asia-Pacific mTOR Inhibitors Sales by Type (2021-2026) & (K Units)
Table 70. Asia-Pacific mTOR Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 71. Asia-Pacific mTOR Inhibitors Sales by Application (2021-2026) & (K Units)
Table 72. South America mTOR Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 73. South America mTOR Inhibitors Sales by Country (2021-2026) & (K Units)
Table 74. South America mTOR Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America mTOR Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 76. South America mTOR Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 77. South America mTOR Inhibitors Sales by Type (2021-2026) & (K Units)
Table 78. South America mTOR Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 79. South America mTOR Inhibitors Sales by Application (2021-2026) & (K Units)
Table 80. Middle East & Africa mTOR Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 81. Middle East & Africa mTOR Inhibitors Sales by Country (2021-2026) & (K Units)
Table 82. Middle East & Africa mTOR Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa mTOR Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa mTOR Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 85. Middle East & Africa mTOR Inhibitors Sales by Type (2021-2026) & (K Units)
Table 86. Middle East & Africa mTOR Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 87. Middle East & Africa mTOR Inhibitors Sales by Application (2021-2026) & (K Units)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. mTOR Inhibitors Typical Distributors
Table 91. mTOR Inhibitors Typical Customers
List of Figures
Figure 1. mTOR Inhibitors Picture
Figure 2. Global mTOR Inhibitors Sales Market Share by Type in 2020
Figure 3. Rapamune
Figure 4. Torisel
Figure 5. Afinitor
Figure 6. Zortress
Figure 7. Global mTOR Inhibitors Sales Market Share by Application in 2020
Figure 8. Tumor Treatment
Figure 9. Kidney Transplant
Figure 10. Others
Figure 11. Global mTOR Inhibitors Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global mTOR Inhibitors Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey mTOR Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global mTOR Inhibitors Sales (2016-2026) & (K Units)
Figure 33. Global mTOR Inhibitors Production Capacity (2016-2026) & (K Units)
Figure 34. Global mTOR Inhibitors Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. mTOR Inhibitors Market Drivers
Figure 36. mTOR Inhibitors Market Restraints
Figure 37. mTOR Inhibitors Market Trends
Figure 38. Global mTOR Inhibitors Sales Market Share by Manufacturer in 2020
Figure 39. Global mTOR Inhibitors Revenue Market Share by Manufacturer in 2020
Figure 40. mTOR Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 mTOR Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 mTOR Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 43. Global mTOR Inhibitors Sales Market Share by Region (2016-2026)
Figure 44. Global mTOR Inhibitors Revenue Market Share by Region (2016-2026)
Figure 45. North America mTOR Inhibitors Revenue (2016-2026) & (USD Million)
Figure 46. Europe mTOR Inhibitors Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific mTOR Inhibitors Revenue (2016-2026) & (USD Million)
Figure 48. South America mTOR Inhibitors Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa mTOR Inhibitors Revenue (2016-2026) & (USD Million)
Figure 50. Global mTOR Inhibitors Sales Market Share by Type (2016-2026)
Figure 51. Global mTOR Inhibitors Revenue Market Share by Type (2016-2026)
Figure 52. Global mTOR Inhibitors Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global mTOR Inhibitors Sales Market Share by Application (2016-2026)
Figure 54. Global mTOR Inhibitors Revenue Market Share by Application (2016-2026)
Figure 55. Global mTOR Inhibitors Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America mTOR Inhibitors Sales Market Share by Country (2016-2026)
Figure 57. North America mTOR Inhibitors Revenue Market Share by Country (2016-2026)
Figure 58. North America mTOR Inhibitors Sales Market Share by Type (2016-2026)
Figure 59. North America mTOR Inhibitors Sales Market Share by Application (2016-2026)
Figure 60. Europe mTOR Inhibitors Sales Market Share by Country (2016-2026)
Figure 61. Europe mTOR Inhibitors Revenue Market Share by Country (2016-2026)
Figure 62. Europe mTOR Inhibitors Sales Market Share by Type (2016-2026)
Figure 63. Europe mTOR Inhibitors Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific mTOR Inhibitors Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific mTOR Inhibitors Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific mTOR Inhibitors Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific mTOR Inhibitors Sales Market Share by Application (2016-2026)
Figure 68. South America mTOR Inhibitors Sales Market Share by Country (2016-2026)
Figure 69. South America mTOR Inhibitors Revenue Market Share by Country (2016-2026)
Figure 70. South America mTOR Inhibitors Sales Market Share by Type (2016-2026)
Figure 71. South America mTOR Inhibitors Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa mTOR Inhibitors Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa mTOR Inhibitors Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa mTOR Inhibitors Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa mTOR Inhibitors Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のTNF阻害剤市場規模・現状・予測（2021年-2027年） TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…- 世界のシグナル伝達阻害剤市場規模・現状・予測（2021年-2027年） Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues. Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibit…
- 世界の可逆性モノアミン系抗うつ阻害剤（RIMA）市場規模・現状・予測（2021年-2027年） RIMAs are used as antidepressants. They work by reducing the activity of monoamine oxidase which is a chemical found throughout the body. Monoamine oxidase breaks down noradrenaline (also called norepinephrine) and serotonin and other chemicals made and used by the body and brain. These chemicals ar…
- 世界の腐食・スケール抑制剤市場 2021：企業別、地域別、種類・用途別 The Corrosion and Scale Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のジペプチジルペプチダーゼIV（DPP-IV）阻害剤市場 2021：企業別、地域別、種類・用途別 The Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…